Erowid References Database
|
Wolff K, Hay AW, Sherlock K, Conner M.
“Contents of 'ecstasy'”.
Lancet. 1995 Oct;346(8982):1100-1.
|
|
Abstract
The risk of adverse reactions to 3,4- methylenedioxymethamphetamine (MDMA) ('ecstasy') is widely known. However, it is still not clear how some can use this drug regularly without harm, whilst others die or have a severe toxic reaction. A range of tablets or capsules are sold as 'ecstasy'. Under a Home Office licence, we have recently analysed 'ecstasy' tablets which were handed in to the Leeds Addiction Unit under an amnesty. The tablets came from all parts of the UK.
|
| # |
| Submit Comment |
|
[
Cite HTML ]
